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Incubation of hepatocytes in the presence of microcystin-LR, okadaic acid, calyculin A (inhibitors of protein phosphatases PPI and PP2A) or 
microcystin-RR (a specific inhibitor of PP2A) activated glucose-6-phosphatase both in the supernatant and in intact or disrupted microsomes. 
Puromycin, an inhibitor of protein synthesis, totally suppressed this activating effect, suggesting the involvement of protem phosphatases in the 
regulation of glucose-6-phosphatase synthesis. 
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1. INTRODUCTION 
Liver plays a major role in the homeostasic regulation 
of blood glucose level. Gluconeogenesis and glyco- 
genolysis are the two metabolic pathways producing 
glucose, and glucose-6-phosphatase (EC 3.1.3.9) cata- 
lyzes the terminal step of both pathways. Despite the 
physiological importance of this enzyme, little is known 
about it’s regulation. There are been numerous reports 
of compounds modifying glucose-6-phosphatase activ- 
ity in vitro ([l-3] for reviews) but no report of acute 
regulation of the enzymatic activity. 
In the present work, we report acute activation of 
glucose-6-phosphatase in rat hepatocytes incubated 
with microcystin-LR, an inhibitor of protein 
phosphatases (PPl and PP2A) [4]. Our results suggest 
that glucose-6-phosphatase may be regulated by phos- 
phorylation at the level of protein synthesis. 
2. MATERIALS AND METHODS 
1.1. Materials 
Glucose-6-phosphate (monosodium salt), mannose-6-phosphate 
(disodium salt), histone 2A, sodium cacodylate, microcystin-LR, mi- 
crocystin-PR, okadaic acid, calyculin A and puromycin, were pur- 
chased from Sigma. Other biochemical reagents were of analytical 
grade. 
2.2. Preparation of hepatoc.vtes 
Hepatocytes were isolated as described previously [5] from 24 h 
fasted male Wistar rats (20&220 g). The isolated hepatocytes (6&80 
mg wet wt./ml) were shaken (165 cycles/min) in stoppered scintillation 
vials at 37°C for 45 min, except where otherwise stated. The incuba- 
tion medium was a Krebs-Henseleit bicarbonate buffer at pH 7.4 in 
equilibrium with a gas phase of O&O, (19:l). 
2.3. Preparation of microsomes 
At the end of incubation, cells were diluted in an equal volume of 
ice-cold 0.25 M sucrose, 5 mM HEPES buffer, pH 7.4 (buffer A) and 
spun down rapidly (1 min at 500 x g). The cell pellet was homogenized 
in the same volume of buffer A in a Teflon-glass homogenizer (20 
strokes) and centrifuged for 10 min at 10,000 x g. An aliquot of the 
supematant was assayed immediately and the remaining supematant 
centrifuged for 60 min at 105,000 x g. The resulting microsomal pellet 
was resuspended in 3 ml/g wet wt. of original cells in buffer A. The 
proportion of intact microsomes was ascertained by measuring the 
latency of low K,,, mannose-6-phosphatase activity [6]. In all the prep- 
arations, microsomes were more than 90% Intact; moreover addition 
of the different effecters did not significantly change the number of 
intact microsomes (data not shown). 
2.4. Assays 
Glucose-6-phosphatase and mannose-6-phosphatase activities were 
assayed as in [7] except that the inorganic phosphate released was 
measured according to Fiske and Subarrow [8]. Glucose-6-phosphat- 
ase activity was routinely measured in the presence of 20 mM glucose- 
6-phosphate. For kinetic studies the glucose-6-phosphate concentra- 
tions used were 0.4.0.8, 1.25,2.5,5,10 and 20 mM. K,,, and V,,, values 
were determined from Lineweaver-Burk plots. In experiments using 
disrupted microsomes, histone 2A (1 mg/ml) was added to the assay 
mixture. Protein concentration was determined by the method of 
Lowry [9]. 
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Fig. 1. Influence of various microcystm-LR concentrations on glu- 
case-6-phosphatase activity in hepatocytes. The values are mean 
? S.E.M. for four cell preparations (except for 200 nM microcystin- 
LR, n = 2). *Significantly different (P < 0.05) from values in the ab- 
3. RESULTS AND DISCUSSION 
3.1. Microcystin-LR activates glucose-6-phosphatase 
As shown in Table I, glucose-6-phosphatase activity 
in supernatants was 1.9-fold higher in isolated hepato- 
cytes incubated for 45 min in the presence of 100 nM 
microcystin-LR than in control cells. The increase in 
glucose-6-phosphatase activity was also observed in in- 
tact microsomal structures, although to a lesser extent 
than in the supernatant. Addition of microcystin-LR to 
hepatocytes caused a significant increase in the V,,, 
value of glucose-6-phosphatase without altering the K,,, 
value (Table I). 
Glucose-6-phosphatase activity in intact microsomal 
structures has been proposed to be a measure of com- 
bined rates of glucose-6-phosphatase enzyme and of 
three transport proteins, Tl, T2 and T3, which trans- 
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(P c 0.05) from values in the absence of microcystin-LR. 
Fig. 2. Time-course of activation of glucose-6-phosphatase by micro- 
cystin-LR in hepatocytes. Hepatocytes were incubated with 10 mM 
dihydroxyacetone and m the absence (0) or in the presence of 100 nM 
microcystm-LR (0) for the indicated periods of time. The values are 
mean f S.E.M. for four cell preparations. *Significantly dtfferent 
port glucose-6-phosphate, phosphate and glucose, re- 
spectively, across the microsomal membrane [2,3,10]. 
To determine whether microcystin-LR was activating 
the glucose-6-phosphatase enzyme or one of the trans- 
port proteins, glucose-6-phosphatase activity was meas- 
ured after microsomal vesicles had been fully disrupted. 
Microcystin-LR increased glucose-6-phosphatase activ- 
ity at the same extent in intact and disrupted micro- 
somes (Table I); moreover, in disrupted microsomes, 
like results obtained using intact microsomes, microcys- 
tin-LR significantly increased the V,,,,, value despite a 
low but significant increase in the K,,, value. Therefore, 
microcystin-LR seemed to induce an activation of glu- 
case-6-phosphatase enzyme rather than a modification 
of the transport proteins. As shown in Fig. 1, half- 
maximum and maximum effects were obtained with 100 





Effect of microcystin-LR on activity and kinettc constants of glucose-6-phosphatase in hepatocytes 
Control + Microcystin-LR 
(nmol/min per mg) (5) 232 5 43 f 6* 
intact (nmol/min per mg) (9) 139 + 12 199 + 15* 
drsrupted (nmol/min per mg) (9) 250 + 23 353 + 32* 
Intact K, (mM) (6) 3.36 + 0.63 2.96 f 0.67 
V 
rll.aY 
(nmol/min per mg) (6) 199 + 17 272 + 13* 
dtsrupted K, (mM) (4) 1.15 + 0.14 1.56 f 0.09* 
1’ rndX 
(nmol/min per mg) (4) 537 f 43* 
Hepatocytes were incubated with 10 mM dihydroxyacetone in the presence of 100 nM microcystin-LR as indicated. The values are mean ? S.E.M. 
for the number of cell preparations indicated in parentheses, *Significantly different (P < 0.05) from the control values. 
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Supernatant 
Table II 
Influence of various inhibitors of protein phosphatases on the glucose-6-phosphatase activity in hepatocytes 
Control + Microcystin-LR + Okadaic acid + Calyculin A 
(nmol/min per mg) 36 f I 61 f I* 61 f 8* 55 f 12* 
Microsomes intact 
(nmol/min per mg) 
disrupted 
(nmoYmin per mg) 
138 f 19 178 + 20* 
228 + 34 296 f 31* 
177 f 12* 
316 t 39* 
174f22* 
299 f 34* 
Hepatocytes were incubated m the presence of 100 nM microcystin-LR, 1 PM okadaic acid or 1 ,DM calycuhn A as Indicated. The values are 
mean + S.E.M. for five cell preparations. *Significantly different (P < 0.05) from the control values. 
3.2. Inhibition ofprotein phosphatases activates glucose- 
6-phosphatase 
The microcystin effect on glucose-6-phosphatase ac- 
tivity seemed to be related to inhibition of protein 
phosphatases during the incubation of hepatocytes. In- 
deed, two other chemically different inhibitors of PPl 
and PP2A (okadaic acid and calyculin A) [11,12] also 
increased glucose-6-phosphatase activity, both in the 
supernatant and in intact or disrupted microsomes 
(Table II). Moreover, microcystin-RR, a specific inhib- 
itor of protein phosphatase 2A [13], was also able to 
significantly activate glucose-6-phosphatase in the su- 
pernatant (control 29 + 5 nmol/min per mg; + 2 ,uM 
microcystin-RR-treated hepatocytes 46 + 5 nmol/min 
per mg; P < 0.05, n = 4) and in intact or disrupted mi- 
crosomes (control 133 + 13 or 241 + 18 nmol/min per 
mg, respectively; + 2 ,uM microcystin-RR-treated hepa- 
tocytes 160 ? 12 or 283 f 15 nmol/min per mg, respec- 
tively; P < 0.05, n = 4). Since enzymatic activity itself 
was unaffected by inclusion in assays of any of these 
compounds (not shown), it could be concluded that the 
observed activation of glucose-6-phosphatase enzyme 
may be related to an inhibition of protein phosphatases 
and, more probably, of protein phosphatase 2A. More- 
over. these results also suggested the involvement of a 
phosphorylation mechanism in this phenomenon. 
3.3. Puromycin suppresses microcystin effect on glucose- 
6-phosphatase activation 
Two main mechanisms may participate in the activa- 
tion of an enzyme by phosphorylation: firstly, a direct 
phosphorylation of the enzyme by a protein kinase and 
(or), secondly, an increase in its synthesis by a phospho- 
rylation mechanism [14]. Thus, we tested the influence 
of puromycin (an inhibitor of protein synthesis) on the 
effect of microcystin on glucose-6-phosphatase activa- 
tion. Incubation of hepatocytes in the presence of puro- 
mycin totally suppressed the activation of glucose-6- 
phosphatase by microcystin-LR both in the supernatant 
and on intact or disrupted microsomes (Table III); sim- 
ilar results were obtained in hepatocytes treated with 
200 nM microcystin-LR (not shown). These results sug- 
gested an acute regulation of the glucose-6- phosphatase 
enzyme by phosphorylation at the level of protein syn- 
thesis. As shown in Fig. 2, activation of glucose-6-phos- 
phatase by microcystin-LR significantly appeared after 
15 min incubation: this lag-time was also consistent with 
such an interpretation. Moreover, incubation of hepa- 
tocytes in the presence of puromycin totally suppressed 
the activation of glucose-6-phosphatase by microcystin- 
RR both in the supernatant and on intact or disrupted 
microsomes (Table III). All these results suggested the 
involvement of protein phosphatases. most probably 
Table III 
Influence of puromycin on the microcystin effect on glucose-6-phosphatase activity in hepatocytes 
Control + Microsystm-LR Control + Microcystin-RR 
Supernatant (nmollmin per mg) Control 40 f 6 64f 3* 36 50 
+ Puromycm 46 t 3 41 + 3** 37 40 
Microsomes intact Control 151 f 3 1902 3* 148 174 
(nmohmm per mg) + Puromycin 159f4 157It 9** 153 158 
disrupted Control 207 f 5 213 f 4* 259 297 
(nmollmin per mg) + Puromycin 229 f 5 229? lo** 259 258 
Hepatocytes were incubated in the presence of 100 nM microcystin-LR, 2 ,DM microcystin-RR or 1 mM puromycin as indicated. The values are 
mean f S.E.M. for five (microcystin-LR) or two (microcystin-RR) cell preparations. *Significantly different (P < 0.05) from values in the absence 
of microcystin-LR; **Sigmticantly different (P < 0.05) from values in the presence of microcystin-LR but in the absence of puromycm. 
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PP2A, in the regulation of glucose-6-phosphatase yn- 
thesis. This was consistent with the proposed role for 
PP2A in the regulation of protein synthesis [15,16]. 
A direct dephosphorylation of the enzyme might ex- 
plain the lesser extent of glucose-6-phosphatase activa- 
tion in the presence of protein phosphatase inhibitors 
observed in microsomes than in the supernatant (Tables 
I-III). However, total suppression of the microcystin- 
LR effect by puromycin observed in the supernatant 
(Table III) ruled out a possible contribution of an acti- 
vation of glucose-6-phosphatase by direct phosphoryla- 
tion. 
In conclusion, our results clearly demonstrate an 
acute activation of the hepatic glucose-6-phosphatase 
enzyme by inhibition of protein phosphatases, most 
probably by PP2A. These results also suggest he in- 
volvement of a phosphorylation mechanism in the regu- 
lation of the glucose-6-phosphatase enzyme at the level 
of protein synthesis. 
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